Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) (FRA:RN3N) is a biopharmaceutical company focused on developing novel, small molecule drugs with optimized receptor pharmacology designed to deliver broad clinical utility across multiple therapeutic areas. Arena’s proprietary pipeline includes potentially first- or best-in-class programs for which they own global commercial rights. Arena’s APD371, a CB2 agonist, is in clinical-stage studies. The CB2 receptor is part of the naturally occurring cannabinoid receptor system in our bodies.
Directions to listing
Send Message to listing owner
Listing Title: Arena Pharmaceuticals, Inc.